Survival in age-related macular degeneration (AMD) may be lower in patients with late disease, bilateral cataract surgery and poor visual acuity, according to data from the Age-Related Eye Disease Study 2. Moreover, oral supplementation with omega-3 fatty acids, lutein plus zeaxanthin, zinc or beta-carotene does not significantly affect mortality.
The effectiveness and safety profile of Aurolab aqueous drainage implant (AADI) are similar with published reports of the Baerveldt glaucoma implant (BGI) and Ahmed glaucoma valve implant in patients with refractory childhood glaucoma, making AADI a viable low-cost glaucoma drainage device (GDD), reports a recent study.
The use of atropine appears to prevent myopic progression, as supported by level I evidence, according to a recent study. Additionally, myopic rebound has been reported after treatment discontinuation, but this is minimized by using low doses, particularly atropine 0.01%.
Long-term use of hydroxychloroquine (HCQ) increases the risk of HCQ retinal toxicity, according to a recent study involving the Korean population. Other risk factors include daily HCQ dose and the presence of kidney disease.
Potential toxic optic neuropathy (TON) is common in workers with occupational exposure to unburnt tobacco, shows a recent study from India, which also finds advancing age and longer exposure duration as independent predictors of the condition.
Fluocinolone acetonide implant and systemic corticosteroid therapy both improve vision-related quality of life (VRQoL) in patients with noninfectious uveitis, according to a study. However, the implant group shows an immediate improvement as compared to gradual for the systemic group.
In diabetic macular oedema (DME), visual outcomes following intravitreal dexamethasone implant therapy may be predicted by early treatment response, according to a study. Specifically, eyes with optimal early responses demonstrate better outcomes compared with eyes having suboptimal early visual acuity gains.
Combining the DASH (Dietary Approaches to Stop Hypertension) diet with low sodium intake reduces systolic blood pressure (SBP) in individuals with pre- and stage 1 hypertension, with progressively higher reductions at greater levels of baseline SBP, a recent study has shown.
At a symposium during the 25th Congress of the Obstetrical and Gynaecological Society of Malaysia in Kuala Lumpur, Professor Susan Davis discussed the unique implications of women living decades beyond menopause, and how healthcare professionals can best manage menopausal symptoms in the short and long term.